| Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma M Castro, J Corren, ID Pavord, J Maspero, S Wenzel, KF Rabe, ... New England journal of medicine 378 (26), 2486-2496, 2018 | 1603 | 2018 |
| Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a … S Wenzel, M Castro, J Corren, J Maspero, L Wang, B Zhang, G Pirozzi, ... The Lancet 388 (10039), 31-44, 2016 | 957 | 2016 |
| Prenatal polycyclic aromatic hydrocarbon (PAH) exposure and child behavior at age 6–7 years FP Perera, D Tang, S Wang, J Vishnevetsky, B Zhang, D Diaz, D Camann, ... Environmental health perspectives 120 (6), 921-926, 2012 | 420 | 2012 |
| Polycyclic aromatic hydrocarbons–aromatic DNA adducts in cord blood and behavior scores in New York City children FP Perera, S Wang, J Vishnevetsky, B Zhang, KJ Cole, D Tang, V Rauh, ... Environmental health perspectives 119 (8), 1176-1181, 2011 | 349* | 2011 |
| Multivariate linear and nonlinear causality tests Z Bai, WK Wong, B Zhang Mathematics and Computers in simulation 81 (1), 5-17, 2010 | 170* | 2010 |
| Liberty Asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate … WW Busse, JF Maspero, KF Rabe, A Papi, SE Wenzel, LB Ford, ID Pavord, ... Advances in therapy 35, 737-748, 2018 | 162 | 2018 |
| Repeated exposure to polycyclic aromatic hydrocarbons and asthma: effect of seroatopy KH Jung, B Yan, K Moors, SN Chillrud, MS Perzanowski, RM Whyatt, ... Annals of Allergy, Asthma & Immunology 109 (4), 249-254, 2012 | 55 | 2012 |
| Multivariate causality tests with simulation and application Z Bai, H Li, WK Wong, B Zhang Statistics & probability letters 81 (8), 1063-1071, 2011 | 50 | 2011 |
| Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma M Castro, KF Rabe, J Corren, ID Pavord, CH Katelaris, Y Tohda, B Zhang, ... ERJ open research 6 (1), 2020 | 48 | 2020 |
| Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients S Wenzel, B Swanson, A Teper, J Hamilton, K Izuhara, S Ohta, J Ono, ... European Respiratory Journal 48 (suppl 60), 2016 | 22 | 2016 |
| Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST SE Wenzel, I Pavord, B Zhang, J Maroni, P Rowe, JD Hamilton, ... C101. ASTHMA CLINICAL AND MECHANISTIC STUDIES, A5949-A5949, 2018 | 16 | 2018 |
| Dupilumab reduces severe exacerbation rate and improves lung function in adolescent patients with uncontrolled, moderate-to-severe asthma: from the Liberty Asthma Quest study J Maspero, M Fitzgerald, IAN Pavord, S Wenzel, B Zhang, J Maroni, ... Chest 154 (4), 25A-27A, 2018 | 13 | 2018 |
| Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST W Busse, JF Maspero, CH Katelaris, D Saralaya, S Guillonneau, B Zhang, ... European Respiratory Journal 52 (suppl 62), 2018 | 13 | 2018 |
| Significant interactions between maternal PAH exposure and haplotypes in candidate genes on B[a]P-DNA adducts in a NYC cohort of non-smoking African … S Iyer, F Perera, B Zhang, S Chanock, S Wang, D Tang Carcinogenesis 35 (1), 69-75, 2014 | 12 | 2014 |
| Dupilumab suppresses fractional exhaled nitric oxide (FeNO) and biomarkers of type 2 inflammation in adult patients with persistent uncontrolled asthma despite use of medium-to … BN Swanson, A Teper, JD Hamilton, B Zhang, H Staudinger, N Tian, ... Journal of Allergy and Clinical Immunology 137 (2), AB190, 2016 | 8 | 2016 |
| Dupilumab Treatment Produces Rapid and Sustained Improvements in FEV1 in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY … M Castro, WW Busse, B Zhang, J Maroni, P Rowe, N Amin, G Pirozzi, ... D12. IMMUNOTHERAPY IN LUNG DISEASE, A6163-A6163, 2018 | 6 | 2018 |
| A randomized, controlled phase 3 study, LIBERTY ASTHMA QUEST, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma M Castro, J Corren, ID Pavord, JF Maspero, SE Wenzel, KF Rabe, ... A101. MECHANISMS AND CLINICAL FEATURES OF SEVERE ASTHMA, A7700-A7700, 2018 | 5 | 2018 |
| Dupilumab improves asthma outcomes regardless of baseline lung function C Katelaris, K Rabe, J Corren, D Langton, P Bardin, H Park, H Park, ... Respirology 24, 110-110, 2019 | 4 | 2019 |
| Prenatal and postnatal exposure to polycyclic aromatic hydrocarbons and asthma: effect of Atopy at Ages 5-6 yrs in an urban birth cohort K Jung, S Hsu, K Moors, K Bernabe, B Yan, SN Chillrud, R Whyatt, ... Journal of Allergy and Clinical Immunology 127 (2), AB3, 2011 | 4 | 2011 |
| Dupilumab improves lung function and reduces severe exacerbations in patients with uncontrolled persistent asthma with and without history of atopy J Maspero, SM Gawchik, B Zhang, G Pirozzi, H Staudinger, RR Evans, ... Allergy 71, 530-530, 2016 | 3 | 2016 |
